World Health Organization (WHO) 2008 Report on the Global AIDS Epidemic. World Health Organization; Geneva: 2008.
 Merson MH. The HIV-AIDS pandemic at 25 -- the global response. N Engl J Med. 2006 Jun 8;354(23):2414–7. [PubMed]
 United Nations (UN) The Millennium Development Goals Report 2009. United Nations; New York, NY: 2009.
 United Nations (UN) United Nations Millennium Declaration. UN; New York: 2000.
 Joint United Nations Programme on HIV/AIDS (UNAIDS) What Countries Need: Investments Needed for 2010 Targets. UNAIDS; Geneva: 2009.
 Celentano DD, Davis WW, Beyrer C. Epidemiology of HIV/AIDS in low- and middle-income countries: where global AIDS is and where it is going. Public Health Aspects of HIV/AIDS in Low and Middle Income Countries. 2008:3–17.
 World Health Organization (WHO) Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector - Progress Report 2009. WHO; Geneva: 2009.
 Stover J, Bertozzi S, Gutierrez J-P, Walker N, Stanecki KA, Greener R, et al. The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science. 2006 March 10;311(5766):1474–6. 2006. [PubMed]
 World Health Organization (WHO) Joint United Nations Programme on HIV/AIDS (UNAIDS) UNICEF Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. World Health Organization, UNAIDS, UNICEF; Geneva: 2008.
 Global HIV Prevention Working Group Bringing HIV Prevention to Scale: An Urgent Global Priority. Global HIV Prevention Working Group; Washington, DC: 2007.
 Merson MH, O'Malley J, Serwadda D, Apisuk C. The history and challenge of HIV prevention. Lancet. 2008 Aug 15;372(9637):475–88. [PubMed]  Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008 Aug 29;372(9639):669–84. [PMC free article] [PubMed]  Piot P, Bartos M, Larson H, Zewdie D, Mane P. Coming to terms with complexity: a call to action for HIV prevention. Lancet. 2008 Sep 12;372(9641):845–59. [PubMed]  Horton R, Das P. Putting prevention at the forefront of HIV/AIDS. Lancet. 2008 Aug 15;372(9637):421–2. [PubMed]  Collins C, Coates TJ, Curran J. Moving beyond the alphabet soup of HIV prevention. AIDS. 2008;22(Suppl(2)):S5–S8. [PMC free article] [PubMed]
 Schmid C, McColl W. The AIDS Drug Assistance Program: Securing HIV/AIDS Drugs for the Nation's Poor and Uninsured. The AIDS Institute and the AIDS Action Foundation; Washington, DC: 2008.
 Bassett IV, Farel C, Szmuilowicz ED, Walensky RP. HIV/AIDS: AIDS Drug Assistance Programs in the era of routine HIV testing. Clin Inf Dis. 2008;47(5):695–701. [PMC free article] [PubMed]
 The World Bank Averting a Human Crisis During the Global Downturn: Policy Options from the World Bank's Human Development Network. The World Bank; Washington, DC: 2009.
 Joint United Nations Programme on HIV/AIDS (UNAIDS) HIV Prevention Needs and Successes: A Tale of Three Countries. An update on HIV Prevention Success in Senegal, Thailand and Uganda. UNAIDS; Geneva: 2001.
 Committee on HIV Prevention Strategies in the United States No Time To Lose: Getting More from HIV Prevention. Institute of Medicine, Division of Health Promotion and Disease Prevention; Washington, DC: 2001.
 Kerr T, Wodak A, Elliott R, Montaner JS, Wood E. Opioid substitution and HIV/AIDS treatment and prevention. Lancet. 2004 Dec 3;364(9449):1918–9. [PubMed]  Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15(11):1329–41. [PubMed]  McFarlane DR. Reproductive health policies in President Bush's second term: old battles and new fronts in the United States and internationally. J Public Health Policy. 2006;27(4):405–26. [PubMed]  Anonymous HIV prevention policy needs an urgent cure. Lancet. 2006 Apr 15;367(9518):1213. [PubMed]
 Nelson R. Report shows mixed results for PEPFAR. Lancet Infect Dis. 2006;6(4):194.
 Bertozzi SM, Laga M, Bautista-Arredondo S, Coutinho A. Making HIV prevention programmes work. Lancet. 2008 Sep 12;372(9641):831–44. [PubMed]  Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ. 2005 Dec 17;331(7530):1431–7. [PMC free article] [PubMed]
 Hillier FS, Lieberman GJ. Introduction to Operations Research. McGraw-Hill; Boston: 2005.
 Lasry A, Richter A, Lutscher F. Recommendations for increasing the use of HIV/AIDS resource allocation models. BMC Public Health. 2009 Nov 18;9(Suppl 1):S8. [PMC free article] [PubMed]  Lasry A, Carter MW, Zaric GS. S4HARA: System for HIV/AIDS resource allocation. Cost Eff Resour Alloc. 2008;6:7. [PMC free article] [PubMed]
 Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics, Part I. Proceedings of the Royal Statistical Society, Series A. 1927;115:700–21.
 Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics, Part II. Proceedings of the Royal Statistical Society, Series A. 1932;138:55–83.
 Kaplan EH. Economic evaluation and HIV prevention community planning: a policy analyst's perspective. In: Holtgrave DR, editor. Handbook of Economic Evaluation of HIV Prevention Programs. Plenum Press; New York: 1998.
 Hethcote HW. The mathematics of infectious diseases. SIAM Review. 2000;42(4):599–653.
 Hethcote HW. Qualitative analyses of communicable disease models. Math Biosci. 1976;28:335–56.
 Wickwire K. Mathematical models for the control of pests and infectious diseases: A survey. Theoretical Population Biology. 1977;11(2):182–238. [PubMed]
 Sethi SP. Optimal quarantine programmes for controlling an epidemic spread. J Operational Res Soc. 1978;29(3):265–8.
 Sethi SP, Preston WS. Optimal control of some simple deterministic epidemic models. J Operational Res Soc. 1978;29(2):129–36.
 Greenhalgh D. Control of an epidemic spreading in a heterogeneously mixing population. Math Biosci. 1986;80(1):23–45.
 Friedrich CM, Brandeau ML. Using simulation to find optimal funding levels for HIV prevention programs with different costs and effectiveness. In: Anderson JG, Katzper M, editors. Proceedings of the 1998 Medical Sciences Simulation Conference; San Diego, CA. Society for Computer Simulation International; 1998. 1998.
 Richter A, Brandeau ML, Owens DK. An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users. Med Decis Making. 1999 April 1;19(2):167–79. 1999. [PubMed]
 Revelle C, Feldmann F, Lynn W. An optimization model of tuberculosis epidemiology. Manage Sci. 1969;16(4):B190–B211.
 Longini IM, Ackerman E, Elveback LR. An optimization model for influenza A epidemics. Math Biosci. 1978;38(1–2):141–57.
 Hethcote HW, Yorke JA, Nold A. Gonorrhea modeling: a comparison of control methods. Math Biosci. 1982;58(1):93–109.
 Brandeau ML. Allocating resources to control infectious diseases. In: Brandeau ML, Sainfort F, Pierskalla WP, editors. Operations Research and Health Care: Methods and Applications. Kluwer Academic Publishers; Norwell, MA: 2004. pp. 443–64.
 Zaric GS. Resource allocation for control of infectious disease epidemics. Comments on Theoretical Biology. 2003;8:475–96.
 Dandona L, Kumar SP, Ramesh Y, Rao MC, Kumar AA, Marseille E, et al. Changing cost of HIV interventions in the context of scaling-up in India. AIDS. 2008 Jul;22(Suppl 1):S43–9. [PubMed]  Dandona L, Sisodia P, Kumar S, Ramesh Y, Kumar A, Rao M, et al. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency. BMC Public Health. 2005;5:98. [PMC free article] [PubMed]  Guinness L, Kumaranayake L, Hanson K. A cost function for HIV prevention services: is there a 'u' -shape? Cost Eff Resour Alloc. 2007 Nov 5;5:13. [PMC free article] [PubMed]  Kaplan EH. Economic analysis of needle exchange. AIDS. 1995;9(10):1113–9. [PubMed]  Marseille E, Dandona L, Marshall N, Gaist P, Bautista-Arredondo S, Rollins B, et al. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Services Research. 2007;7(1):108. [PMC free article] [PubMed]  Kim SY, Goldie SJ. Cost-effectiveness analyses of vaccination programmes. Pharmacoeconomics. 2008;26(3):191–215. [PubMed]
 Long EF, Brandeau ML. OR's next top model: Decision models for infectious disease control. In: Gray P, editor. TutORials in Operations Research. Institute for Operations Research and the Management Sciences (INFORMS); Baltimore, MD: 2009. pp. 123–38.
 Ruiz M, Gable A, Kaplan EH, Stoto M, Fineberg H, Trussell J, editors. No Time to Lose: Getting More from HIV Prevention. National Academy Press; Washington, DC: 2001.
 Martello S, Toth P. Knapsack Problems: Algorithms and Computer Implementations. Wiley; New York: 1990.
 Kaplan EH, Pollack H. Allocating HIV prevention resources. Socio-Econ Plann Sci. 1998;32(4):257–63.
 Kahn JG. The cost-effectiveness of HIV prevention targeting: how much more bang for the buck? Am J Public Health. 1996 December 1;86(12):1709–12. 1996. [PubMed]
 Paltiel D. Timing is of the essence - Matching AIDS policy to the epidemic life cycle. In: Kaplan EH, Brandeau ML, editors. Modeling the AIDS Epidemic: Planning, Policy, and Prediction. Raven Press, Ltd.; New York, NY: 1994.
 Zaric GS, Brandeau ML. Resource allocation for epidemic control over short time horizons. Math Biosci. 2001;171(1):33–58. [PubMed]
 Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford University Press; Oxford: 1991.
 Bernstein RS, Sokal DC, Seitz ST, Auvert B, Stover J, Naamara W. Simulating the control of a heterosexual HIV epidemic in a severely affected East African city. Interfaces. 1998;28(3):101–26.
 Robinson NJ, Mulder DW, Auvert B, Hayes RJ. Modelling the impact of alternative HIV intervention strategies in rural Uganda. AIDS. 1995;9(11):1263–70. [PubMed]  Bautista-Arredondo S, Gadsden P, Harris JE, Bertozzi SM. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework. AIDS. 2008;22:S67–S74. [PubMed]  Brandeau ML, Zaric GS. Optimal investment in HIV prevention programs: more is not always better. Health Care Manage Sci. 2009;12(1):27–37. [PMC free article] [PubMed]  Kumaranayake L. The economics of scaling up: cost estimation for HIV/AIDS interventions. AIDS. 2008;22:S23–S33. [PubMed]  Brandeau ML, Zaric GS, De Angelis V. Improved allocation of HIV prevention resources: Using information about prevention program production functions. Health Care Manage Sci. 2005;8(1):19–28. [PubMed]  Castilla J, del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J AIDS. 2005;40(1):96–101. [PubMed]  Egger M, May M, Chêne G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360(9327):119–29. [PubMed]  Grabar S, Moing VL, Goujard C, Leport C, Kazatchkine MD, Costagliola D, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med. 2000 Sep 19;133(6):401–10. [PubMed]  Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV. N Engl J Med. 1997 Apr 10;336(15):1072–8. [PubMed]  Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JSG. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 109 cells/L. Ann Intern Med. 2003 Nov 18;139(10):810–6. [PubMed]  Cleary SM, McIntyre D, Boulle AM. Assessing efficiency and costs of scaling up HIV treatment. AIDS. 2008;22(Suppl(1)):S35–S42. [PubMed]  Broomberg J, Söderlund N, Mills A. Economic analysis at the global level: a resource requirement model for HIV prevention in developing countries. Health Policy. 1996;38(1):45–65. [PubMed]  El-Sadr WM, Abrams EJ. Scale-up of HIV care and treatment: Can it transform healthcare services in resource-limited settings? AIDS. 2007 Oct;21(Suppl 5):S65–70. [PubMed]  Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural approaches to HIV prevention. Lancet. 2008 Sep 5;372(9640):764–75. [PubMed]  Rauner MS, Brandeau ML. AIDS policy modeling for the 21st century: An overview of key issues. Health Care Manage Sci. 2001;4(3):165–80. [PubMed]  Hirschhorn LR, Ojikutu B, Rodriguez W. Research for change: Using implementation research to strengthen HIV care and treatment scale-up in resource-limited settings. J Infect Dis. 2007;196(s3):S516–S22. [PubMed]
 Joint United Nations Programme on HIV/AIDS (UNAIDS) UNAIDS Practical Guidelines for Intensifying HIV Prevention - Towards Universal Access. UNAIDS; Geneva: 2007.
 Wilson D, Halperin DT. “Know your epidemic, know your response”: a useful approach, if we get it right. Lancet. 2008 Aug 15;372(9637):423–6. [PubMed]  Johnson-Masotti AP, Pinkerton SD, Holtgrave DR, Valdiserri RO, Willingham M. Decision-making in HIV prevention community planning: An integrative review. J Community Health. 2000;25(2):95–112. [PubMed]  Kaplan EH, Merson MH. Allocating HIV-prevention resources: balancing efficiency and equity. Am J Public Health. 2002 Dec;92(12):1905–7. [PubMed]  Kerr NL, Tindale RS. Group performance and decision making. Ann Rev Psychol. 2004 Feb;55:623–55. [PubMed]  Zaric GS, Brandeau ML. Optimal investment in a portfolio of HIV prevention programs. Med Decis Making. 2001 October 1;21(5):391–408. 2001. [PubMed]  Earnshaw SR, Hicks K, Richter A, Honeycutt A. A linear programming model for allocating HIV prevention funds with state agencies: a pilot study. Health Care Manage Sci. 2007 Sep;10(3):239–52. [PubMed]  Richter A, Hicks KA, Earnshaw SR, Honeycutt AA. Allocating HIV prevention resources: a tool for state and local decision making. Health Policy. 2008 Sep;87(3):342–9. [PubMed]
 Stover J, Bollinger L, Cooper-Arnold K. GOALS Model for Estimating the Effects of Resource Allocation Decisions on the Achievement of the Goals of the HIV/AIDS Strategic Plan. The Futures Group International; Washington, DC: 2003.
 Stover J, Walker N, Garnett GP, Salomon JA, Stanecki KA, Ghys PD, et al. Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet. 2002;360:73. [PubMed]  Brandeau ML, McCoy JH, Hupert NA, Holty J-E, Bravata DM. Recommendations for modeling crisis response in public health and medicine: A position paper of the Society for Medical Decision Making. Med Decis Making. 2009;29:438–60. [PubMed]  University of Maryland and the Advanced Practice Center for Public Health Emergency Preparedness and Response of Montgomery County Maryland. [Apr 13, 2010];Software for improving mass dispensing and vaccination clinic operations. 2008 Accessed at < http://www.isr.umd.edu/Labs/CIM/projects/clinic/software.html>.